Cargando…

ML-13 The primary treatment outcomes and future problems of PCNSL elderly patients in our institute

Background and purpose: Since the introduction of HD-MTX, cognitive symptoms after irradiation have become a problem mainly in elderly patients. In this study, we evaluated the treatment outcomes of over 70 years old PCNSL patients after HD-MTX introduction. Subjects and methods: From April 2009 to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kambe, Atsushi, Amisaki, Hidefumi, Kuwamoto, Yuhei, Shimizu, Tsuyoshi, Nakajima, Sadao, Torihashi, Koichi, Uno, Tetsuji, Sakamoto, Makoto, Kurosaki, Masamichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Supplement Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699090/ http://dx.doi.org/10.1093/noajnl/vdaa143.073

Ejemplares similares

Endovascular Mechanical Thrombectomy with a Large-Bore Aspiration Catheter and Stent Retriever for Cerebral Venous Sinus Thrombosis in Pregnancy: A Case Report
por: Shimizu, Tsuyoshi, et al.
Publicado: (2022)

ML-11 Tirabrutinib treatment for recurrent or refractory PCNSL
por: Ohka, Fumiharu, et al.
Publicado: (2021)

ML-17 Clinical usefulness of Tirabrutinib in recurrent PCNSL: single institute experience
por: Matsuura, Jin, et al.
Publicado: (2021)

ML-15 The future direction of treatment development for primary central nervous system lymphoma (PCNSL)
por: Shinojima, Naoki, et al.
Publicado: (2020)

ML-14 Re-challenge and maintenance therapy of methotrexate for elderly PCNSL patients with low scored KPS
por: Yamaguchi, Takashi, et al.
Publicado: (2020)

ML-12 Clinical impact and management of skin-related disorders during treatment of relapsed PCNSL by tirabrutinib
por: Sasaki, Nobuyoshi, et al.
Publicado: (2021)

ML-07 High expression of PD-L1 on tumor-associated macrophage is a predictive factor for favorable prognosis in PCNSL
por: Furuse, Motomasa, et al.
Publicado: (2020)

ML-5 THE TRANSITION OF THE TREATMENT OF 60 PCNSL CASES AT OUR INSTITUTION AND CLINICAL CONSIDERATIONS
por: Yoshitake, Hidenobu, et al.
Publicado: (2022)

Primary Intracranial Neuroendocrine Tumor of the Skull Base Complicated with Tension Pneumocephalus after Radiotherapy
por: KAMBE, Atsushi, et al.
Publicado: (2021)

ML-09 The REAL-WORLD of Elderly PCNSL Therapy in Tohoku and Niigata Area According to Retrospective Analysis: A Collaborative Investigation of the Tohoku Brain Tumor Study Group
por: Asano, Kenichiro, et al.
Publicado: (2020)

Transcondylar fossa approach for the large, high-flow, and diffuse arteriovenous malformation of the posterior fossa
por: Torihashi, Koichi, et al.
Publicado: (2021)

ML-12 HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION (HDC-ASCT) FOR THE PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)
por: Miyakita, Yasuji, et al.
Publicado: (2022)

ML-13 AN ATTEMPT OF RECHALLENGE OF HD-MTX AND MAINTENANCE THERAPY OF MTX FOR PATIENTS WITH PCNSL
por: Yamaguchi, Takashi, et al.
Publicado: (2019)

ML-4 POLICY CHANGE TO PCNSL TREATMENT LED BY HEMATOLOGY, AND INITIAL TREATMENT RESULTS
por: Hashiba, Tetsuo, et al.
Publicado: (2022)

ML-18 Clinical diagnosis for suspected primary central nervous system lymphoma patients without histopathological confirmation
por: Osawa, Sho, et al.
Publicado: (2020)

Transbrachial Mechanical Thrombectomy for Acute Ischemic Stroke in Marfan’s Syndrome: A Case Report
por: Shimizu, Tsuyoshi, et al.
Publicado: (2022)

ML-06 Diagnostic value of liquid biopsy for CNS lymphoma by detection of specific gene mutations in the cerebrospinal fluid
por: Yamagishi, Yuki, et al.
Publicado: (2020)

ML-7 Liquid biopsy for MYD88 mutation in cerebrospinal fluid in patients with suspected primary CNS lymphoma
por: Yuki, Yamagishi, et al.
Publicado: (2021)

Isolated Oculomotor Nerve Palsy after Mechanical Thrombectomy for Middle Cerebral Artery Occlusion: A Case Report
por: Amisaki, Hidefumi, et al.
Publicado: (2023)

Treatment outcome and prognostic factors in PCNSL
por: Niparuck, Pimjai, et al.
Publicado: (2019)

ML-02 Chemotherapy for patients with relapsed or refractory primary CNS lymphoma
por: Nagane, Motoo, et al.
Publicado: (2020)

ML-21 Tirabrutinib monotherapy for relapsed/refractory primary central nervous system lymphoma
por: Kobayashi, Keiichi, et al.
Publicado: (2020)

ML-08 Safety and efficacy of consolidation cytarabine for newly-diagnosed primary central nervous system lymphoma
por: Sasaki, Nobuyoshi, et al.
Publicado: (2020)

Different imaging patterns of PCNSL and IVL: a case report
por: Jeon, Seung-Ho, et al.
Publicado: (2019)

Liquid Biopsy and Other Non-Invasive Diagnostic Measures in PCNSL
por: Baraniskin, Alexander, et al.
Publicado: (2021)

ML-23 The outcome of malignant lymphoma of the central nervous system in a single institution
por: Kuwahara, Kiyonori, et al.
Publicado: (2020)

ML-01 Pathological characteristics of primary central nervous system lymphoma with atypical radiological finding
por: Inukai, Madoka, et al.
Publicado: (2020)

Focal nodular hyperplasia that mimicked a liver metastasis from a soft tissue sarcoma: a case report
por: Amisaki, Masataka, et al.
Publicado: (2017)

Burden of Illness: Costs and Consequences of Our Fragmented Mental Health Care System
por: Arizpe, Michael, et al.
Publicado: (2006)

STMO-12 Efforts for safe malignant brain tumor surgery at our hospital
por: Kobayashi, Yusuke, et al.
Publicado: (2021)

CLRM-15 TRIAL IN PROGRESS: A PHASE 1B/2 STUDY OF GB5121, A NOVEL, HIGHLY SELECTIVE, POTENT, AND CNS-PENETRANT INHIBITOR OF BRUTON’S TYROSINE KINASE (BTKI) FOR RELAPSED/REFRACTORY PRIMARY/SECONDARY CNS LYMPHOMA (R/R PCNSL/SCNSL) AND PRIMARY VITREORETINAL LYMPHOMA (PVRL)
por: Soussain, Carole, et al.
Publicado: (2022)

Comment — WHO is badly in need of reform, but it cannot replace NGOs like our own
por: Liu, Joanne
Publicado: (2017)

Smoking and Drinking Habits Five Years after Baseline in the JACC Study
por: Kawado, Miyuki, et al.
Publicado: (2005)

ML-4 A case of primary CNS lymphoma diagnosed 5 years after stereotactic radiosurgery
por: Tabei, Yusuke, et al.
Publicado: (2021)

GSEA-assisted gene signatures valid for combinations of prognostic markers in PCNSL
por: Takashima, Yasuo, et al.
Publicado: (2020)

A Case of Intracranial Subependymoma: Histopathological Confirmation of Ring-shaped Lateral Ventricular Nodule
por: Kuya, Keita, et al.
Publicado: (2017)

ML-13 Primary central nervous system malignant lymphoma in a patient with rheumatoid arthritis receiving tocilizumab
por: Ohno, Masasuke, et al.
Publicado: (2021)

ML-20 Outcome of high-dose methotrexate-based chemotherapy with or without Rituximab for primary central nervous system lymphoma
por: Takezaki, Tatsuya, et al.
Publicado: (2020)

ML-04 The influence of surgical intervention for high-dose Methotrexate chemotherapy in the patients with primary central nervous system lymphoma
por: Okamoto, Michinari, et al.
Publicado: (2020)

ML-16 First clinical experience of administration of Tirabrutinib for the patients with newly diagnosed primary central nervous system lymphoma
por: Onodera, Sho, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7de2pono35j4ai648d38sa1hcm